Medically reviewed by Jay N. Yepuri, MD Medically reviewed by Jay N. Yepuri, MD A pancreatic elastase test, also known as a ...

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

Wave Life Sciences' WVE-006 demonstrates first-ever RNA editing in humans for alpha-1 antitrypsin deficiency, showing ...

Wave claims this is the first clinical data with a therapeutic RNA-editing drug in humans, an achievement that boosted its ...

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...

Dapeng Chen and colleagues have designed a medical device that measures the protease activity of human neutrophil elastase in human breath with high sensitivity. The over-release of neutrophil ...

In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Wave Life Sciences (WVE – Research Report), with ...

Dapeng Chen and colleagues have designed a medical device that measures the protease activity of human neutrophil elastase in human breath with high sensitivity. The over-release of neutrophil ...

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. Lower respiratory tract infections, such as bronchitis, pneumonia ...

Krystal Biotech is gearing up for a very important Q4 of 2024, because it is gearing up to report data from two different ...